HOME >> BIOLOGY >> NEWS
New anti-inflammatory strategy for cancer therapy identified by UCSD researchers

A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system's inflammatory response into a cancer-killing outcome, is suggested in research findings by investigators at the University of California, San Diego (UCSD) School of Medicine.

The findings provide new insight into the immune system's response to inflammation, the connection between inflammation and malignancy, and how the delicate balance between cancer promotion and inhibition can be manipulated in the patient's favor, according to the study's senior author, Michael Karin, Ph.D., UCSD professor of pharmacology, American Cancer Society Research Professor, and a member of the Rebecca and John Moores UCSD Cancer Center.

The studies in mice with colon or breast cancer showed that cancer metastasis, the growth of malignant tumors beyond the original site, was halted with inhibition of either one of two naturally occurring substances, a pro-inflammatory protein called nuclear factor-kappa B (NF-kB) or an inflammatory mediator called tumor necrosis factor alpha (TNFα). The result, published in the September 20, 2004 issue of the journal Cancer Cell, was increased effectiveness of a cancer-killing protein called TNF-related apoptosis-inducing ligand (TRAIL), leading to a decrease in cancer cells and increase in the life span of tumor-bearing mice.

The study's first author, Jun-Li Luo, M.D., Ph.D., a member of the Karin team in the UCSD Laboratory of Gene Regulation and Signal Transduction, explained that normally, inflammation associated with malignancy activates NF-kB, TNFα and TRAIL, all at the same time. However, NF-kB has the upper hand, and with TNFα, stimulates tumor growth faster than TRAIL can inhibit it.

"Our results suggest that is it possible to use NF-kB or TNFα inhibitors to prevent inflammation-induced tumor growth, thus destroying their advantage, and allowing TRAIL to tip the balance in its favor,"
'"/>

Contact: Sue Pondrom
spondrom@ucsd.edu
619-543-6163
University of California - San Diego
20-Sep-2004


Page: 1 2 3 4

Related biology news :

1. Anti-cancer agent built from anti-inflammatory drug
2. Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
3. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
4. The anti-inflammatory effect of apoptotic bodies
5. Herb used to treat migraine headaches could be used to develop new anti-inflammatory drugs
6. MetaPhore reports general anti-inflammatory surface treatment for biomedical materials
7. Common anti-inflammatory drug rescues low-growth fetuses in mouse study
8. A novel, safer strategy for regulating gene expression
9. European common frog found to use novel mating strategy
10. Promising hospital anti-infection strategy probably wont work, study shows
11. Parasitic cowbirds thrive with a less ruthless strategy than cuckoos

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2020)... ... 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year in ... HCC is the 5th most common cancer and the 2nd leading cause of cancer ... incidence of HCC, while China has half of all patients suffering from liver cancer. ...
(Date:1/29/2020)... ... 29, 2020 , ... VGXI, a world leading contract manufacturer ... vaccine against the novel coronavirus (2019-nCoV) that has recently emerged in Wuhan, China ... million from the Coalition for Epidemic Preparedness Innovations (CEPI) will fund the vaccine ...
(Date:1/27/2020)... DIEGO (PRWEB) , ... January 27, 2020 , ... ... Thorne as Chairman. Thorne is a noted investor, tech entrepreneur, and former senior ... as Executive Chairman of Broadline Capital, the global alternative investment firm. , ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery ... Southern Midwest Region Industrial and Institutional (I&I) Account Manager. Darrell will focus on ... , Darrell brings over 30 years of sales experience working across multiple different ...
(Date:1/10/2020)... ... January 09, 2020 , ... GenScript Biotech Corp., ... Biotech Global Forum on Jan. 14 in San Francisco, coinciding with the JP ... and the Booming China Market," will feature gene and cell therapy leaders in ...
(Date:1/7/2020)... Mass. (PRWEB) , ... January 06, 2020 , ... ... for a Digital World at The Fletcher School at Tufts University, is pleased ... Sloan Foundation. The grant will be administered by Tufts University, and will help ...
(Date:12/30/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... December ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... its new SIMS Version 1.11.19 21 CFR Part 11 compliant software program specific ...
Breaking Biology Technology:
Cached News: